Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.


TSX:CTX - Post by User

Bullboard Posts
Comment by Schaffhausenon Apr 08, 2016 8:02am
201 Views
Post# 24744103

RE:RE:Emotion Has Left the Building

RE:RE:Emotion Has Left the Building
Crescita was, and is, a bad idea (maybe?!?!). Management is terrible, but I am talking about something entirely different. What I mean to say is that at the current share price, Crescita is extremely exposed to a junk bid buyout. Has nothing to do with management and everything to do with the assets and a shareholder base looking to cash out the $35MM. That is why I say that you couldn't rip these shares from my hands for less than $3.50, the same way you wouldn't change a $20 bill for $10. At $1.50 the downside is gone and this is why this is a speculative hold for me. I see in the trading patterns that there seems to be careful buyers for anyone who loses their patience. I have no problem being patient with this one. Having said that, here's to hoping that management does what they say they will do and in their own words "preserve cash". Maybe the split was intended to package Crescita as the buyout rather than NRI as we have all been suspecting. Time will tell, but their are so many strange and mysterious management actions that I feel something must have been in the works that is yet to be revealed. Quite frankly the shareprice of Crescita is on solid ground at 1.50 and I intend to read to the final chapter. Cheers, Schaff
Bullboard Posts